Hansa Biopharma AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2019-11-05 | Hansa Biopharma AB | Ulf Wiinberg | Styrelseledamot/suppleant | Acquisition | 15 000 | 123,57 | SEK | 1 853 550 | 2019-11-03 |
| 2019-12-13 | Hansa Biopharma AB | Eva-Maria Joed | Vice President Finance and Administration | Acquisition | 1 000 | 73,15 | SEK | 73 150 | 2019-12-12 |
| 2019-12-16 | Hansa Biopharma AB | Andreas Eggert | Board member/Board Deputy | Acquisition | 3 000 | 6,425 | EUR | 19 275 | 2019-12-15 |
| 2019-12-17 | Hansa Biopharma AB | Sören Tulstrup | VD | Acquisition | 5 000 | 71,551 | SEK | 357 755 | 2019-12-15 |
| 2019-12-17 | Hansa Biopharma AB | Eva Nilsagård | Styrelseledamot/suppleant | Acquisition | 3 000 | 68,78 | SEK | 206 340 | 2019-12-16 |
| 2019-12-18 | Hansa Biopharma AB | Ulf Wiinberg | Styrelseordförande | Acquisition | 14 350 | 70,94 | SEK | 1 017 989 | 2019-12-16 |
| 2019-12-18 | Hansa Biopharma AB | Birgit Agneta Stattin Norinder | Styrelseledamot/suppleant | Acquisition | 3 000 | 71 | SEK | 213 000 | 2019-12-16 |
| 2019-12-20 | Hansa Biopharma AB | Vincenza Nigro | VP of Global Medical Affairs | Acquisition | 3 000 | 69,75 | SEK | 209 250 | 2019-12-16 |
| 2019-12-20 | Hansa Biopharma AB | Anders gersel Pedersen | Board member | Acquisition | 2 500 | 72,6 | SEK | 181 500 | 2019-12-17 |
| 2019-12-21 | Hansa Biopharma AB | Max Sakajja | Vice President Corporate Strategy | Acquisition | 1 000 | 78,3 | SEK | 78 300 | 2019-12-18 |
| 2019-12-21 | Hansa Biopharma AB | Max Sakajja | Vice President Corporate Strategy | Acquisition | 1 000 | 76,26 | SEK | 76 260 | 2019-12-19 |
| 2020-03-06 | Hansa Biopharma AB | Klaus Lykke Sindahl | VP, Head of Investor Relations | Acquisition | 555 | 89,5 | SEK | 49 672,5 | 2020-03-05 |
| 2020-08-11 | Hansa Biopharma AB | Klaus Lykke Sindahl | VP, Head of Investor Relations | Acquisition | 300 | 256 | SEK | 76 800 | 2020-08-10 |
| 2020-09-07 | Hansa Biopharma AB | Klaus Lykke Sindahl | VP, Head of IR | Acquisition | 745 | 194 | SEK | 144 530 | 2020-09-06 |
| 2021-01-19 | Hansa Biopharma AB | Petrus Lindh | Other member of the company's administrative, management or supervisory body | Acquisition | 300 | 185,7 | SEK | 55 710 | 2021-01-18 |
| 2021-02-23 | Hansa Biopharma AB | Klaus Lykke Sindahl | Other member of the company's administrative, management or supervisory body | Acquisition | 592 | 169,6 | SEK | 100 403,2 | 2021-02-21 |
| 2021-05-09 | Hansa Biopharma AB | Soren Tulstrup | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 3 000 | 150,276 | SEK | 450 827,25 | 2021-05-06 |
| 2021-05-12 | Hansa Biopharma AB | Klaus Lykke Sindahl | Other member of the company's administrative, management or supervisory body | Acquisition | 1 200 | 140,75 | SEK | 168 900 | 2021-05-10 |
| 2021-07-16 | Hansa Biopharma AB | Soren Tulstrup | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 2 000 | 111,186 | SEK | 222 371,35 | 2021-07-15 |
| 2021-07-19 | Hansa Biopharma AB | Ulf Wiinberg | Chairman of the Board of Directors | Acquisition | 10 000 | 112,22 | SEK | 1 122 200 | 2021-07-15 |